Nomad Power Solutions (NMAD) Non-Current Assets (2018 - 2026)
Nomad Power Solutions (NMAD) posted Non-Current Assets of $7.3 million for Q2 2026, down 2.72% on a QoQ basis from $7.6 million in Q4 2025, and up 3596.62% year-over-year from $198826.0 in Q2 2025.
Analysis
Nomad Power Solutions (NMAD) Non-Current Assets (2018 - 2026) Analysis & Trends
Nomad Power Solutions has reported Non-Current Assets for 7 years, with the latest figure at $7.3 million in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 3596.62% year-over-year to $7.3 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a 7240.76% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, changed N/A from the prior year.
- Non-Current Assets was $7.3 million for Q2 2026 at Nomad Power Solutions, down from $7.6 million in the prior quarter.
- The five-year high for Non-Current Assets was $7.6 million in Q4 2025, with the low at $6928.0 in Q3 2024.
- Average Non-Current Assets over 4 years is $3.0 million, with a median of $198826.0 recorded in 2025.
- The largest YoY upside for Non-Current Assets was 3596.62% in 2026 against a maximum downside of 3596.62% in 2026.
- Over 4 years, Non-Current Assets stood at $10906.0 in 2022, then tumbled by 36.48% to $6928.0 in 2024, then soared by 108953.72% to $7.6 million in 2025, then fell by 2.72% to $7.3 million in 2026.
- The last three Non-Current Assets figures came in at $7.3 million (Q2 2026), $7.6 million (Q4 2025), and $198826.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 60.68 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 35.42 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 14.88 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 23.28 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.96 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 5.15 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 938.60 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 24.78 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 564.41 Mn |
| 10 | Nomad Power Solutions | 49.59 Mn | 49.59 Mn | - | 7.35 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.35 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Jun 30, 2025 | 198,826.00 |
| Sep 30, 2024 | 6,928.00 |
| Mar 31, 2022 | 10,906.00 |
| Sep 30, 2021 | 26,376.00 |
| Sep 30, 2020 | 174,253.00 |
| Jun 30, 2020 | 86,850.00 |
| Dec 31, 2018 | 2,293.00 |
| Sep 30, 2018 | 4,587.00 |
| Jun 30, 2018 | 6,880.00 |